TY - JOUR T1 - Drug-induced modulation of gp130 signalling prevents articular cartilage degeneration and promotes repair JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - 760 LP - 769 DO - 10.1136/annrheumdis-2017-212037 VL - 77 IS - 5 AU - Ruzanna Shkhyan AU - Ben Van Handel AU - Jacob Bogdanov AU - Siyoung Lee AU - Yifan Yu AU - Mila Scheinberg AU - Nicholas W Banks AU - Sean Limfat AU - Arthur Chernostrik AU - Carlos Eduardo Franciozi AU - Mohammad Parvez Alam AU - Varghese John AU - Ling Wu AU - Gabriel B Ferguson AU - Ali Nsair AU - Frank A Petrigliano AU - C Thomas Vangsness AU - Kanagasabai Vadivel AU - Paul Bajaj AU - Liming Wang AU - Nancy Q Liu AU - Denis Evseenko Y1 - 2018/05/01 UR - http://ard.bmj.com/content/77/5/760.abstract N2 - Objective Human adult articular cartilage (AC) has little capacity for repair, and joint surface injuries often result in osteoarthritis (OA), characterised by loss of matrix, hypertrophy and chondrocyte apoptosis. Inflammation mediated by interleukin (IL)-6 family cytokines has been identified as a critical driver of proarthritic changes in mouse and human joints, resulting in a feed-forward process driving expression of matrix degrading enzymes and IL-6 itself. Here we show that signalling through glycoprotein 130 (gp130), the common receptor for IL-6 family cytokines, can have both context-specific and cytokine-specific effects on articular chondrocytes and that a small molecule gp130 modulator can bias signalling towards anti-inflammatory and antidegenerative outputs.Methods High throughput screening of 170 000 compounds identified a small molecule gp130 modulator termed regulator of cartilage growth and differentiation (RCGD 423) that promotes atypical homodimeric signalling in the absence of cytokine ligands, driving transient increases in MYC and pSTAT3 while suppressing oncostatin M- and IL-6-mediated activation of ERK and NF-κB via direct competition for gp130 occupancy.Results This small molecule increased proliferation while reducing apoptosis and hypertrophic responses in adult chondrocytes in vitro. In a rat partial meniscectomy model, RCGD 423 greatly reduced chondrocyte hypertrophy, loss and degeneration while increasing chondrocyte proliferation beyond that observed in response to injury. Moreover, RCGD 423 improved cartilage healing in a rat full-thickness osteochondral defect model, increasing proliferation of mesenchymal cells in the defect and also inhibiting breakdown of cartilage matrix in de novo generated cartilage.Conclusion These results identify a novel strategy for AC remediation via small molecule-mediated modulation of gp130 signalling. ER -